Keep Me Logged In
Andrew Witty, Global CEO, GlaxosmithKline speaks to CNBC TV-18's Shereen Bhan on the current patent price debate in the drug industry. He states GSK will continue striving to defend tier pricing.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2018 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by